Background: Ashy dermatosis or Erythema Dyschromicum Perstans is a rare disorder of unknown etiology characterized by asymptomatic,slowly progressive, ashen-gray macular pigmentation of the skin. Various therapies have been tried without any benefit. The anti-inflammatory activity of dapsone on Erythema Dyschromicum Perstans may be the first oral treatment option. Objective: The aim of the present study was to evaluate the efficacy of dapsone in the treatment of ashy dermatosis. Methodology: This study was carried out on total thirty (30) 
Introduction

Ashy dermatosis or Erythema Dyschromicum Perstans (EDP)
is an acquired generalized dermal hypermelanosis of unknown etiology 1 . The disease is characterized by hyperpigmented macules and patches of various shape and size with an ashen-grey to brown blue colour 1,2 . In the early stage they may have a thin very fine (several mm) raised erythematous, non scaling border feeling like a cord 2 . This border later can be absent or mainly in darker skin types, evolve into a hypopigmented border that accentuates the hyperpigmentation 
Methodology
This study was carried out for a period of two years from January 2010 to December 2011 in the Department of Dermatology & Venereology at Shaheed Suhrawardy Medical College Hospital (ShSMCH) and Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka. Total thirty patients of ashy dermatosis were selected considering exclusion criteria like patients with known hypersensitivity to any ingredients of the dapsone, pregnancy, lactation, impaired hepatic function, impaired renal function and severe systemic illness, any medication that interfere with dapsone. The inclusion criteria of patients selection were included both male & female of young adult, patient willing to give consent to take part in the study, patient expected to be available for the duration of the study and able to comply with the study visit, Patients with ashy dermatosis diagnosed clinically and confirmed by histopathological examination and patients received no topical or systemic treatment for four weeks prior and during the protocol. Serum Glucose 6-phosphate dehydrogenase level was done in each patient and was revealed normal. Skin biopsy from the affected area was taken in all cases for histopathological examination to confirm the diagnosis. Complete blood count with ESR, platelet count, urine for M/E, fasting blood sugar, liver function test (SGPT, SGOT), renal function test (serum creatinine), Glucose 6-phosphate dehydrogenase were done. The study group was treated with the dapsone 100 mg (tab Anasone/ lepsone 100 mg) daily for three months. Dapsone may produce hematological, hepatic, gastrointestinal, neurological, psychiatric and hypersensitivity reaction. The clinical response and adverse effects of treatment were assessed in 1½ monthly follow up by clinical examination among all study people (n=30). The clinical response of the treatment was measured (the hyperpiguented area) by taken photograph befoer & after the treatment. Excellent response when >75% improvement occur; good response when 50-75% clearing of the lesion, fair 25-50% clearing and poor when 25% clearing of skin lesion occurred. After collection of data, they were screened by checking consistency, edited and were finally analyzed by software Statistical Package for Social Science (SPSS).
Results
The study was conducted on 30 patients of ashy dermatosis. Most the patient were in the age group of 36 to 40 years and the mean age ±SD was 43.50 ± 2.21 years (Table 1) .
Female was predominant than male which was 16(53.3%) and 14(46.7%) cases respectively (Table 2 ).
During study period there were no cases of haematological, hepatic, gastrointestinal, neurological, and psychiatric or hypersensitivity disorders found in 1st follow up as well as 2nd follow up.
The most common site of involvement of ashy dermatitis has been found in the trunk which was 11(36.7%) cases followed by neck and lower extremity which were 9(30.0%) cases and 7(23.3%) cases respectively (Table 3 ). The therapeutic response of ashy dermatosis among the patients was observed with a high response (56.7%) than poor or no
